Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $4.46M | 3,379,736 | 40.87% | 59.13% | Net Buying | Net Buying | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $9.35M | 12,810,377 | 51.46% | 48.54% | ||||
| PSTV | PLUS THERAPEUTICS INC | $27.96M | 171,550,698 | 6.73% | 13.93% | Net Buying | |||
| CODX | CO-DIAGNOSTICS INC | $6.70M | 3,602,465 | 34.31% | 65.69% | Net Selling | |||
| SGMO | SANGAMO THERAPEUTICS INC | $102.33M | 414,274,017 | 15.03% | 7.68% | Net Selling | Net Selling | ||
| NRXP | NRX PHARMACEUTICALS INC | $70.43M | 33,067,630 | 9.51% | 90.49% | ||||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.11M | 839,662 | 27.53% | 72.47% | Net Selling | |||
| IMMP | IMMUTEP LTD | $51.73M | 1,473,721,306 | 0.13% | 0.00% | ||||
| PDSB | PDS BIOTECHNOLOGY CORP | $33.77M | 55,815,653 | 14.12% | 21.18% | ||||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $90.91M | 123,692,286 | 36.22% | 33.04% | Net Selling | |||
| ENLV | ENLIVEX LTD | $220.76M | 237,381,498 | 0.56% | 9.27% | ||||
| OSTX | OS THERAPIES INC | $55.74M | 39,533,227 | 4.49% | 16.72% | Net Selling | |||
| GUTS | FRACTYL HEALTH INC | $72.66M | 158,648,963 | 70.87% | 18.33% | Net Buying | |||
| HELP | CYBIN INC | $239.49M | 49,894,131 | 60.30% | 0.00% | ||||
| TVRD | TVARDI THERAPEUTICS INC | $29.83M | 9,381,344 | 8.39% | 91.61% | ||||
| SNTI | SENTI BIOSCIENCES INC | $25.29M | 31,144,497 | 17.99% | 82.01% | ||||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $18.57M | 24,602,405 | 1.41% | 3.40% | ||||
| HOVR | NEW HORIZON AIRCRAFT LTD | $62.40M | 44,252,749 | 2.82% | 20.61% | Net Selling | |||
| HUMA | HUMACYTE INC | $134.77M | 222,019,108 | 24.91% | 13.85% | Net Selling | |||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $4.61M | 2,636,788 | 1.48% | 98.52% | Net Buying | |||
| ACRV | ACRIVON THERAPEUTICS INC | $53.85M | 38,744,446 | 48.03% | 38.25% | Net Selling | Net Buying | ||
| FEMY | FEMASYS INC | $24.56M | 58,479,824 | 16.18% | 4.17% | Net Buying | |||
| CTSO | CYTOSORBENTS CORP | $35.49M | 62,700,000 | 26.89% | 45.29% | Net Buying | |||
| ACET | ADICET BIO INC | $65.35M | 9,596,407 | 29.18% | 70.82% | Net Buying | Net Selling | ||
| VNRX | VOLITIONRX LTD | $24.81M | 122,801,572 | 13.15% | 33.07% | Net Buying | Net Selling | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.28M | 27,074,586 | 1.76% | 98.24% | ||||
| NSRX | NASUS PHARMA LTD | $20.01M | 9,015,383 | 0.03% | 57.27% | ||||
| INTZ | INTRUSION INC | $16.72M | 20,369,066 | 7.93% | 74.72% | Net Buying | Net Selling | ||
| CAN | CANAAN INC | $287.68M | 9,939,193,337 | 1.62% | 3.73% | ||||
| IFRX | INFLARX NV | $64.63M | 72,292,859 | 26.80% | 6.01% | ||||
| TNYA | TENAYA THERAPEUTICS INC | $150.16M | 216,998,876 | 31.61% | 38.17% | Net Selling | Net Selling | ||
| GNLX | GENELUX CORP | $108.43M | 44,805,811 | 20.34% | 6.29% | Net Selling | Net Selling | ||
| RCT | REDCLOUD HOLDINGS PLC | $31.40M | 44,226,639 | 0.80% | 20.60% | ||||
| CLNN | CLENE INC | $58.07M | 11,778,307 | 6.84% | 93.16% | Net Selling | Net Selling | ||
| AVXL | ANAVEX LIFE SCIENCES CORP | $284.50M | 92,671,758 | 40.78% | 4.79% | Net Buying | |||
| CCCC | C4 THERAPEUTICS INC | $256.63M | 97,578,175 | 80.10% | 19.90% | Net Selling | Net Selling | ||
| FGNX | FG NEXUS INC | $32.59M | 6,530,207 | 21.25% | 78.75% | Net Buying | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $367.28M | 266,143,286 | 52.34% | 0.53% | ||||
| CABA | CABALETTA BIO INC | $299.46M | 111,322,671 | 68.49% | 3.91% | Net Buying | Net Buying | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $140.02M | 117,667,277 | 22.52% | 11.52% | Net Selling | Net Selling | ||
| PEPG | PEPGEN INC | $122.33M | 69,115,292 | 83.00% | 9.75% | Net Buying | Net Selling | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $40.48M | 48,596,817 | 25.49% | 74.51% | Net Selling | Net Selling | ||
| PALI | PALISADE BIO INC | $290.30M | 165,884,817 | 81.91% | 5.00% | Net Buying | Net Buying | ||
| BMEA | BIOMEA FUSION INC | $110.62M | 72,299,440 | 32.13% | 25.19% | Net Buying | |||
| ATOS | ATOSSA THERAPEUTICS INC | $45.30M | 8,611,361 | 60.10% | 39.90% | Net Buying | |||
| IVVD | INVIVYD INC | $367.37M | 282,594,729 | 72.23% | 27.77% | Net Selling | Net Selling | ||
| MNOV | MEDICINOVA INC | $67.43M | 49,221,246 | 10.68% | 88.78% | ||||
| ALIT | ALIGHT INC | $311.62M | 534,502,781 | 72.59% | 27.41% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.